πŸ‡ΊπŸ‡Έ FDA
Patent

US 11459564

Modulation of frataxin expression

granted A61KA61K31/7088

Quick answer

US patent 11459564 (Modulation of frataxin expression) held by The Board of Regents of the University of Texas System expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/7088